COVID-19 Impact on Global Drugs for Short Bowel Syndrome Market Size, Status and Forecast 2020-2026

September 2020 | 96 pages | ID: C6781185F964EN
QYResearch

Abstracts

This report focuses on the global Drugs for Short Bowel Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Short Bowel Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Ardelyx
• Emmaus Life Sciences
• GLyPharma Therapeutic
• Merck
• Naia Pharmaceuticals
• Nutrinia
• OxThera
• Sancilio & Company
• Takeda
• Zealand Pharma

Market segment by Type, the product can be split into

• GLP-2
• Growth Hormone
• Glutamine
• Other

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Drugs for Short Bowel Syndrome status, future forecast, growth opportunity, key market and key players.
• To present the Drugs for Short Bowel Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Drugs for Short Bowel Syndrome are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
1.4 Market Analysis by Type
  1.4.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 GLP-2
  1.4.3 Growth Hormone
  1.4.4 Glutamine
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Drugs for Short Bowel Syndrome Industry Impact
  1.6.1 How the Covid-19 is Affecting the Drugs for Short Bowel Syndrome Industry
    1.6.1.1 Drugs for Short Bowel Syndrome Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Drugs for Short Bowel Syndrome Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Drugs for Short Bowel Syndrome Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Drugs for Short Bowel Syndrome Market Perspective (2015-2026)
2.2 Drugs for Short Bowel Syndrome Growth Trends by Regions
  2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Drugs for Short Bowel Syndrome Historic Market Share by Regions (2015-2020)
  2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Drugs for Short Bowel Syndrome Market Growth Strategy
  2.3.6 Primary Interviews with Key Drugs for Short Bowel Syndrome Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Drugs for Short Bowel Syndrome Players by Market Size
  3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2015-2020)
  3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2015-2020)
  3.1.3 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
  3.2.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2019
3.3 Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.4 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.5 Date of Enter into Drugs for Short Bowel Syndrome Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2015-2020)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2021-2026)

5 DRUGS FOR SHORT BOWEL SYNDROME BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Drugs for Short Bowel Syndrome Market Size (2015-2020)
6.2 Drugs for Short Bowel Syndrome Key Players in North America (2019-2020)
6.3 North America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
6.4 North America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Drugs for Short Bowel Syndrome Market Size (2015-2020)
7.2 Drugs for Short Bowel Syndrome Key Players in Europe (2019-2020)
7.3 Europe Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
7.4 Europe Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

8 CHINA

8.1 China Drugs for Short Bowel Syndrome Market Size (2015-2020)
8.2 Drugs for Short Bowel Syndrome Key Players in China (2019-2020)
8.3 China Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
8.4 China Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Drugs for Short Bowel Syndrome Market Size (2015-2020)
9.2 Drugs for Short Bowel Syndrome Key Players in Japan (2019-2020)
9.3 Japan Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
9.4 Japan Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Drugs for Short Bowel Syndrome Market Size (2015-2020)
10.2 Drugs for Short Bowel Syndrome Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
10.4 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

11 INDIA

11.1 India Drugs for Short Bowel Syndrome Market Size (2015-2020)
11.2 Drugs for Short Bowel Syndrome Key Players in India (2019-2020)
11.3 India Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
11.4 India Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Drugs for Short Bowel Syndrome Market Size (2015-2020)
12.2 Drugs for Short Bowel Syndrome Key Players in Central & South America (2019-2020)
12.3 Central & South America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020)
12.4 Central & South America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Ardelyx
  13.1.1 Ardelyx Company Details
  13.1.2 Ardelyx Business Overview and Its Total Revenue
  13.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
  13.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2015-2020))
  13.1.5 Ardelyx Recent Development
13.2 Emmaus Life Sciences
  13.2.1 Emmaus Life Sciences Company Details
  13.2.2 Emmaus Life Sciences Business Overview and Its Total Revenue
  13.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
  13.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.2.5 Emmaus Life Sciences Recent Development
13.3 GLyPharma Therapeutic
  13.3.1 GLyPharma Therapeutic Company Details
  13.3.2 GLyPharma Therapeutic Business Overview and Its Total Revenue
  13.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
  13.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.3.5 GLyPharma Therapeutic Recent Development
13.4 Merck
  13.4.1 Merck Company Details
  13.4.2 Merck Business Overview and Its Total Revenue
  13.4.3 Merck Drugs for Short Bowel Syndrome Introduction
  13.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.4.5 Merck Recent Development
13.5 Naia Pharmaceuticals
  13.5.1 Naia Pharmaceuticals Company Details
  13.5.2 Naia Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
  13.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.5.5 Naia Pharmaceuticals Recent Development
13.6 Nutrinia
  13.6.1 Nutrinia Company Details
  13.6.2 Nutrinia Business Overview and Its Total Revenue
  13.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
  13.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.6.5 Nutrinia Recent Development
13.7 OxThera
  13.7.1 OxThera Company Details
  13.7.2 OxThera Business Overview and Its Total Revenue
  13.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
  13.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.7.5 OxThera Recent Development
13.8 Sancilio & Company
  13.8.1 Sancilio & Company Company Details
  13.8.2 Sancilio & Company Business Overview and Its Total Revenue
  13.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
  13.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.8.5 Sancilio & Company Recent Development
13.9 Takeda
  13.9.1 Takeda Company Details
  13.9.2 Takeda Business Overview and Its Total Revenue
  13.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
  13.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.9.5 Takeda Recent Development
13.10 Zealand Pharma
  13.10.1 Zealand Pharma Company Details
  13.10.2 Zealand Pharma Business Overview and Its Total Revenue
  13.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
  13.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2015-2020)
  13.10.5 Zealand Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Drugs for Short Bowel Syndrome Key Market Segments
Table 2. Key Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
Table 3. Ranking of Global Top Drugs for Short Bowel Syndrome Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of GLP-2
Table 6. Key Players of Growth Hormone
Table 7. Key Players of Glutamine
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Drugs for Short Bowel Syndrome Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Drugs for Short Bowel Syndrome Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Drugs for Short Bowel Syndrome Players to Combat Covid-19 Impact
Table 14. Global Drugs for Short Bowel Syndrome Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Drugs for Short Bowel Syndrome Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Drugs for Short Bowel Syndrome Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Drugs for Short Bowel Syndrome Market Share by Regions (2015-2020)
Table 18. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Drugs for Short Bowel Syndrome Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Drugs for Short Bowel Syndrome Market Growth Strategy
Table 24. Main Points Interviewed from Key Drugs for Short Bowel Syndrome Players
Table 25. Global Drugs for Short Bowel Syndrome Revenue by Players (2015-2020) (Million US$)
Table 26. Global Drugs for Short Bowel Syndrome Market Share by Players (2015-2020)
Table 27. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2019)
Table 28. Global Drugs for Short Bowel Syndrome by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 31. Date of Enter into Drugs for Short Bowel Syndrome Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 34. Global Drugs for Short Bowel Syndrome Market Size Share by Type (2015-2020)
Table 35. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2021-2026)
Table 36. Global Drugs for Short Bowel Syndrome Market Size Share by Application (2015-2020)
Table 37. Global Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 38. Global Drugs for Short Bowel Syndrome Market Size Share by Application (2021-2026)
Table 39. North America Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 41. North America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 42. North America Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 43. North America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 44. North America Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 45. Europe Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 47. Europe Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 49. Europe Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 51. China Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 52. China Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 53. China Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 54. China Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 55. China Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 56. China Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 57. Japan Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 59. Japan Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 61. Japan Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 65. Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 67. Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 69. India Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 70. India Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 71. India Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 72. India Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 73. India Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 74. India Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Drugs for Short Bowel Syndrome Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Drugs for Short Bowel Syndrome Market Share (2019-2020)
Table 77. Central & South America Drugs for Short Bowel Syndrome Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Drugs for Short Bowel Syndrome Market Share by Type (2015-2020)
Table 79. Central & South America Drugs for Short Bowel Syndrome Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Drugs for Short Bowel Syndrome Market Share by Application (2015-2020)
Table 81. Ardelyx Company Details
Table 82. Ardelyx Business Overview
Table 83. Ardelyx Product
Table 84. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 85. Ardelyx Recent Development
Table 86. Emmaus Life Sciences Company Details
Table 87. Emmaus Life Sciences Business Overview
Table 88. Emmaus Life Sciences Product
Table 89. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 90. Emmaus Life Sciences Recent Development
Table 91. GLyPharma Therapeutic Company Details
Table 92. GLyPharma Therapeutic Business Overview
Table 93. GLyPharma Therapeutic Product
Table 94. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 95. GLyPharma Therapeutic Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Product
Table 99. Merck Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 100. Merck Recent Development
Table 101. Naia Pharmaceuticals Company Details
Table 102. Naia Pharmaceuticals Business Overview
Table 103. Naia Pharmaceuticals Product
Table 104. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 105. Naia Pharmaceuticals Recent Development
Table 106. Nutrinia Company Details
Table 107. Nutrinia Business Overview
Table 108. Nutrinia Product
Table 109. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 110. Nutrinia Recent Development
Table 111. OxThera Company Details
Table 112. OxThera Business Overview
Table 113. OxThera Product
Table 114. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 115. OxThera Recent Development
Table 116. Sancilio & Company Business Overview
Table 117. Sancilio & Company Product
Table 118. Sancilio & Company Company Details
Table 119. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 120. Sancilio & Company Recent Development
Table 121. Takeda Company Details
Table 122. Takeda Business Overview
Table 123. Takeda Product
Table 124. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 125. Takeda Recent Development
Table 126. Zealand Pharma Company Details
Table 127. Zealand Pharma Business Overview
Table 128. Zealand Pharma Product
Table 129. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2015-2020) (Million US$)
Table 130. Zealand Pharma Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Drugs for Short Bowel Syndrome Market Share by Type: 2020 VS 2026
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Other Features
Figure 6. Global Drugs for Short Bowel Syndrome Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugs for Short Bowel Syndrome Report Years Considered
Figure 11. Global Drugs for Short Bowel Syndrome Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Drugs for Short Bowel Syndrome Market Share by Regions: 2020 VS 2026
Figure 13. Global Drugs for Short Bowel Syndrome Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Drugs for Short Bowel Syndrome Market Share by Players in 2019
Figure 16. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Short Bowel Syndrome as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2019
Figure 18. North America Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Drugs for Short Bowel Syndrome Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Ardelyx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 27. Emmaus Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 29. GLyPharma Therapeutic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 31. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 33. Naia Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 35. Nutrinia Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 37. OxThera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 39. Sancilio & Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 41. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 43. Zealand Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed